DHG Pharmaceutical JSC (HOSE: DHG)

DHG Pharmaceutical JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	61,629	94,134	34,018	43,374	73,054	70,328
Short-Term Investments	2,650,000	1,960,000	2,265,000	1,975,000	1,974,000	1,628,000
Cash & Short-Term Investments	2,711,629	2,054,134	2,299,018	2,018,374	2,047,054	1,698,328
Cash Growth	14.11%	-10.65%	13.90%	-1.40%	20.53%	37.03%
Accounts Receivable	439,466	528,859	279,862	315,113	363,249	454,884
Other Receivables	71,999	107,787	81,417	77,757	63,328	63,006
Receivables	511,723	636,904	361,537	393,141	426,958	518,324
Inventory	1,387,192	1,534,636	1,250,834	1,072,606	826,585	725,439
Prepaid Expenses	2,719	8,007	10,201	5,827	3,327	2,149
Other Current Assets	94,732	408,511	297,183	237,346	176,875	189,684
Total Current Assets	4,707,995	4,642,193	4,218,772	3,727,293	3,480,800	3,133,924
Property, Plant & Equipment	1,153,211	1,187,884	678,171	631,658	705,687	718,592
Long-Term Investments	4,525	4,175	3,860	4,578	4,388	28,123
Other Intangible Assets	179,983	181,861	201,812	205,780	210,084	210,452
Long-Term Deferred Tax Assets	17,214	16,872	15,845	17,535	16,068	12,347
Other Long-Term Assets	92,242	77,489	49,726	30,822	30,477	43,380
Total Assets	6,155,169	6,110,474	5,168,187	4,617,666	4,447,503	4,146,819
Accounts Payable	224,375	217,976	364,379	201,220	252,271	120,317
Accrued Expenses	241,873	313,579	227,615	257,956	255,737	257,175
Short-Term Debt	810,906	572,165	114,723	207,391	212,272	264,667
Current Income Taxes Payable	33,263	17,365	12,678	4,208	14,624	7,240
Current Unearned Revenue	42,609	43,702	34,043	49,609	49,532	29,295
Other Current Liabilities	479,126	24,454	58,098	37,332	31,999	26,206
Total Current Liabilities	1,832,151	1,189,242	811,537	757,716	816,433	704,899
Other Long-Term Liabilities	69,486	68,298	65,113	66,807	63,031	64,368
Total Liabilities	1,901,637	1,257,540	876,650	824,523	879,464	769,267
Common Stock	1,307,461	1,307,461	1,307,461	1,307,461	1,307,461	1,307,461
Additional Paid-In Capital	6,779	6,779	6,779	6,779	6,779	6,779
Retained Earnings	2,939,293	3,538,695	2,977,297	2,475,770	2,249,731	2,057,902
Total Common Equity	4,253,532	4,852,935	4,291,537	3,790,010	3,563,971	3,372,142
Minority Interest	-	-	-	3,134	4,068	5,410
Shareholders' Equity	4,253,532	4,852,935	4,291,537	3,793,144	3,568,039	3,377,551
Total Liabilities & Equity	6,155,169	6,110,474	5,168,187	4,617,666	4,447,503	4,146,819
Total Debt	810,906	572,165	114,723	207,391	212,272	264,667
Net Cash (Debt)	1,900,723	1,481,969	2,184,294	1,810,982	1,834,783	1,433,662
Net Cash Growth	8.29%	-32.15%	20.61%	-1.30%	27.98%	110.38%
Net Cash Per Share	14537.51	11334.72	16706.39	13851.14	14033.18	10965.24
Filing Date Shares Outstanding	130.75	130.75	130.75	130.75	130.75	130.75
Total Common Shares Outstanding	130.75	130.75	130.75	130.75	130.75	130.75
Working Capital	2,875,844	3,452,951	3,407,236	2,969,577	2,664,367	2,429,025
Book Value Per Share	32532.77	37117.25	32823.45	28987.56	27258.72	25791.54
Tangible Book Value	4,073,549	4,671,074	4,089,725	3,584,230	3,353,886	3,161,690
Tangible Book Value Per Share	31156.19	35726.31	31279.91	27413.67	25651.91	24181.91
Buildings	734,845	575,489	578,613	528,464	528,464	526,332
Machinery	1,303,960	1,029,566	903,189	866,975	875,218	777,105
Construction In Progress	132,154	553,594	92,596	69,508	66,473	28,928

Source: S&P Capital IQ. Standard template. Financial Sources.